DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Self-management of Type 1 Diabetes Under Functional Insulin Therapy

Information source: University Hospital, Montpellier
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Type 1 Diabetes; Basal-bolus Multiple-dily Insulin Injections; Insulin Pump (CSII)

Intervention: Training course to functional insulin therapy (Other); Usual diabetes management. (Other)

Phase: N/A

Status: Not yet recruiting

Sponsored by: University Hospital, Montpellier

Official(s) and/or principal investigator(s):
Elise DUTERTRE, MD, Principal Investigator, Affiliation: CHU Montpellier, France

Overall contact:
Elise DUTERTRE, MD, Phone: +33 4 67 33 83 82, Email: e-dutertre@chu-montpellier.fr

Summary

Therapeutic education of patients is a mandatory component of intensive insulin therapy of type 1 diabetes in order to reach optimal safety and efficacy. Used educational methods aim at facilitating patients' autonomy in their own management of diabetes. Therefore, self-management of patient with type 1 diabetes must be systematically assessed in order to evaluate the effectiveness of education programs .The main objective of this prospective controlled randomized monocentric study is to assess the impact of functional insulin therapy on the level of self-management of patients with type 1 diabetes via Confidence In Diabetes Self-care scale (CIDS) test.

Clinical Details

Official title: Evaluation of Self-management of Patients With Type 1 Diabetes After Education to Functional Insulin Therapy

Study design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label

Primary outcome: To assess the impact of therapeutic education by functional insulin therapy in patients with type 1 diabetes on their ability to disease self-management.

Secondary outcome:

To assess the effect of education to functional insulin therapy on HbA1c level

To assess the effect of education to functional insulin therapy on hypoglycemia frequency

To assess the effect of education to functional insulinotherapy on the score of each of the 20 items of CIDS questioonaire

To assess the validity, the concordance and the sensitivity to change of EAD questionnaire (specific for self-management of diabetes) in comparison with CIDS test

Detailed description: 170 patients with type 1 diabetes, volunteering for education to functional insulin therapy, will be recruited by the Department od Endocrinology, Diabetes, Nutrition of Montpellier University Hospital. After inclusion, the patients will be randomized in 2 groups: group 1 will be immediately trained to functional insulin therapy and group 2 will be trained at the end of the study. The patients will be met as outpatients 3 months after inclusion. The primary endpoint will be the global score for CIDS questionnaire. Secondary endpoints will include: HbA1c level at month 3, frequency of hypoglycemia from inclusion to month 3, scores for each of the 20 items of CIDS questionnaire. An ancillary study will assess: the acceptability of the new EAD questionnaire which specifically evaluates the self-management of diabetes, the concordance validity of EAD and CDIS questionnaires, the reproducibility test-retest, the internal consistency and the sensitivity to change of EAD questionnaire.

Eligibility

Minimum age: 18 Years. Maximum age: 70 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Type 1 diabetes from at least 1 year

- Age from 18 to 70 (70 not included)

- Basal-bolus multiple-dily insulin injections or insulin pump (CSII)

- Informed consent

- Affiliated or benefit from an insurance regimen

Exclusion Criteria:

- Type 2 diabetes

- Unable to make mathematic calculation

- Pregnancy, breast-feeding or absence of effective contraception

- Psychiatric and/or cognitive status uncompatible with study

- Eating disorders

- Law protected person, vulnerable person

Locations and Contacts

Elise DUTERTRE, MD, Phone: +33 4 67 33 83 82, Email: e-dutertre@chu-montpellier.fr

Lapeyronie Hospital - CHU de Montpellier, Montpellier 34295, France; Active, not recruiting
Additional Information

Starting date: December 2014
Last updated: October 20, 2014

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017